We examined whether the addition of another conventional disease-modifying anti-rheumatic drugs ( DMARDs ) to methotrexate ( MTX ) upon infliximab ( IFX ) discontinuation in well-controlled rheumatoid arthritis ( RA ) patients could suppress subsequent disease flare .